DBCO-PEG4-Val-Cit-PAB-MMAF

Modify Date: 2025-08-25 21:35:32

DBCO-PEG4-Val-Cit-PAB-MMAF Structure
DBCO-PEG4-Val-Cit-PAB-MMAF structure
Common Name DBCO-PEG4-Val-Cit-PAB-MMAF
CAS Number 2244602-23-9 Molecular Weight 1672.01
Density N/A Boiling Point N/A
Molecular Formula C88H126N12O20 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of DBCO-PEG4-Val-Cit-PAB-MMAF


DBCO-PEG4-Val-Cit-PAB-MMAF consists a cleavable 4 unit PEG ADC linker (DBCO-PEG4-Val-Cit-PAB) and a potent tubulin polymerization inhibitor (MMAF). DBCO-PEG4-Val-Cit-PAB-MMAF can be used in the synthesis of antibody-drug conjugates (ADCs)[1].

 Names

Name DBCO-PEG4-Val-Cit-PAB-MMAF

 DBCO-PEG4-Val-Cit-PAB-MMAF Biological Activity

Description DBCO-PEG4-Val-Cit-PAB-MMAF consists a cleavable 4 unit PEG ADC linker (DBCO-PEG4-Val-Cit-PAB) and a potent tubulin polymerization inhibitor (MMAF). DBCO-PEG4-Val-Cit-PAB-MMAF can be used in the synthesis of antibody-drug conjugates (ADCs)[1].
Related Catalog
Target

Auristatin

In Vitro ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker[1].
References

[1]. Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017 May;16(5):315-337.

 Chemical & Physical Properties

Molecular Formula C88H126N12O20
Molecular Weight 1672.01
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.